IRIS
LAURIA, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.062
EU - Europa 792
AS - Asia 354
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.045
IT - Italia 426
SG - Singapore 156
CN - Cina 146
NL - Olanda 89
DE - Germania 81
UA - Ucraina 61
FR - Francia 45
FI - Finlandia 36
VN - Vietnam 26
IE - Irlanda 25
IN - India 22
CA - Canada 16
GB - Regno Unito 14
CI - Costa d'Avorio 13
SE - Svezia 7
EU - Europa 2
KR - Corea 2
RO - Romania 2
RS - Serbia 2
BZ - Belize 1
DK - Danimarca 1
IL - Israele 1
IR - Iran 1
MK - Macedonia 1
RU - Federazione Russa 1
SI - Slovenia 1
TN - Tunisia 1
Totale 2.224
Salva come PNG Salva come JPEG
Città #
Chandler 242
Singapore 133
Amsterdam 86
Napoli 86
Millbury 59
Ashburn 53
Jacksonville 46
Santa Clara 46
Beijing 41
Princeton 40
Nanjing 34
Naples 30
Dong Ket 24
Wilmington 20
Des Moines 19
Pune 16
Milan 11
Tianjin 11
Boston 9
Lawrence 9
Ottawa 9
Falls Church 8
Nanchang 8
Shenyang 8
Redwood City 7
Rome 7
Ann Arbor 6
Casoria 6
Jiaxing 6
Rozzano 6
Dallas 5
Helsinki 5
Leawood 5
Salerno 5
Seattle 5
Toronto 5
Bologna 4
Changsha 4
Dearborn 4
Fairfield 4
Menfi 4
Munich 4
San Mateo 4
Taizhou 4
Washington 4
Augusta 3
Battipaglia 3
Dublin 3
Duncan 3
Hangzhou 3
Hebei 3
Jinan 3
Los Angeles 3
Ningbo 3
Pomigliano d'Arco 3
Serravalle Scrivia 3
Villaricca 3
Boardman 2
Caserta 2
Castellammare Di Stabia 2
Catania 2
Cernusco sul Naviglio 2
Guangzhou 2
Hanoi 2
Kunming 2
Latina 2
Mariano Comense 2
Montauro 2
Mugnano Di Napoli 2
Mumbai 2
New York 2
Nola 2
Norwalk 2
Piove Di Sacco 2
Pregnana Milanese 2
Rapolla 2
Scafati 2
Shanghai 2
Suri 2
Teano 2
Andover 1
Ardabil 1
Arzano 1
Aversa 1
Bari 1
Belgrade 1
Belize City 1
Benevento 1
Bozen 1
Caivano 1
Capena 1
Casalnuovo 1
Castelli Calepio 1
Castelvetrano 1
Centrale 1
Cesano 1
Cesenatico 1
Deiva Marina 1
Dongyang 1
Edinburgh 1
Totale 1.254
Salva come PNG Salva come JPEG
Nome #
null 223
Manuale di Oncologia Clinica 101
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 94
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 91
Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine 74
null 67
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. 66
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 61
Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma 51
Chlorambucil, Vincristine and Cytarabine (COA) treatment of low grade lymphomas 49
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues 49
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 49
Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour 48
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 47
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature 45
Advanced and Locally unresectable gastric carcinoma: five years of survival with good quality of life. 42
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. 42
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 42
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 41
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer. 41
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis 41
CAVBP-DEP Altemative Chemotherapy for the treatment of intermediate and high grade non Hodgkin lymphoma: final results of a pilot study. 40
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 39
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 39
Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer 39
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. 37
Bone involvement by adenocarcinoma of the uterine cervix: a rare entity 37
Tumor characteristics and prognosis in familial breast cancer 37
Changing presentation in non Hodgkin lymphoma". 36
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. 35
Comparison of Tropisetron (ICS 205-930) with alizapride plus dexamethasone in the prevention of emesis induced by repeated cisplatin administration. 34
Core curriculum. Oncologia clinica 34
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study 34
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 34
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 34
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. 33
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 33
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 33
Partial deficiency of adrenal 11-hydroxylase: A possible cause of primary hypertension 32
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 30
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 30
Core curriculum. Oncologia clinica 29
'Primary Bone Lymphoma". 28
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy. 27
Capitolo 15: i Tumori Ginecologici 26
Maintenance therapy with recombinant Interferon Alpha-2b (IFN) in prognostically in prognastically unfavourable aggressive non-Hodgkin’s lymphomas. 24
Tailored therapy for aggressive non-Hodgkin’s lymphoma: results of a phase II study with a long-term follow-up. 21
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial. 21
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 20
Salvage chemotherapy for non Hodgldn's lymphoma of unfavorable histology with a combination of CCNU and Vinblastine. 20
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety 17
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. 16
Totale 2.313
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020143 0 0 0 0 0 14 7 7 10 29 36 40
2020/2021267 8 12 31 29 29 26 26 8 34 3 32 29
2021/2022342 8 1 7 5 3 13 6 9 26 40 111 113
2022/2023523 57 65 18 42 57 54 3 39 74 92 16 6
2023/2024284 11 52 32 22 17 47 5 29 4 5 48 12
2024/2025217 63 42 13 20 66 13 0 0 0 0 0 0
Totale 2.313